Quest Diagnostics Inc
NYSE:DGX
Quest Diagnostics Inc
Other Equity
Quest Diagnostics Inc
Other Equity Peer Comparison
Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors
Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Quest Diagnostics Inc
NYSE:DGX
|
Other Equity
-$16m
|
CAGR 3-Years
20%
|
CAGR 5-Years
22%
|
CAGR 10-Years
-4%
|
|
DaVita Inc
NYSE:DVA
|
Other Equity
-$100.1m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-48%
|
|
Chemed Corp
NYSE:CHE
|
Other Equity
$2.1m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
0%
|
|
CVS Health Corp
NYSE:CVS
|
Other Equity
$196m
|
CAGR 3-Years
0%
|
CAGR 5-Years
150%
|
CAGR 10-Years
N/A
|
|
Cigna Corp
NYSE:CI
|
Other Equity
-$2.3B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-9%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Other Equity
-$185.4m
|
CAGR 3-Years
7%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
See Also
What is Quest Diagnostics Inc's Other Equity?
Other Equity
-16m
USD
Based on the financial report for Mar 31, 2024, Quest Diagnostics Inc's Other Equity amounts to -16m USD.
What is Quest Diagnostics Inc's Other Equity growth rate?
Other Equity CAGR 10Y
-4%
Over the last year, the Other Equity growth was 11%. The average annual Other Equity growth rates for Quest Diagnostics Inc have been 20% over the past three years , 22% over the past five years , and -4% over the past ten years .